Literature DB >> 7692603

Squamous cancer of the head and neck: surgical treatment of local and regional recurrence.

J A Ridge1.   

Abstract

Many patients with local and regional recurrences of head and neck squamous cancer will benefit from surgical treatment. Curing a patient with salvage surgery is often possible, especially when the tumor was originally treated with radiation therapy alone. Aggressive surgical treatment is warranted when there is a significant chance for cure or durable palliation, and many patients will benefit from supportive care. The decision to withhold surgery should be adopted only by physicians and surgeons who are intimately familiar with head and neck cancer care.

Entities:  

Mesh:

Year:  1993        PMID: 7692603

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  13 in total

1.  Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck.

Authors:  Nicolas Dornoff; Christian Weiß; Franz Rödel; Jens Wagenblast; Shahram Ghanaati; Nateghian Atefeh; Claus Rödel; Panagiotis Balermpas
Journal:  Strahlenther Onkol       Date:  2015-05-25       Impact factor: 3.621

2.  Volumetric Analysis of Endoscopic and Maxillary Swing Surgical Approaches for Nasopharyngectomy.

Authors:  Nidal Muhanna; Harley Chan; Jimmy Qiu; Michael Daly; Tahsin Khan; Francesco Doglietto; Walter Kucharczyk; David P Goldstein; Jonathan C Irish; John R de Almeida
Journal:  J Neurol Surg B Skull Base       Date:  2018-01-19

3.  Outcome after re-irradiation of head and neck cancer patients.

Authors:  Nele Platteaux; Piet Dirix; Bianca Vanstraelen; Sandra Nuyts
Journal:  Strahlenther Onkol       Date:  2010-12-22       Impact factor: 3.621

Review 4.  Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma.

Authors:  Antoine Digonnet; Marc Hamoir; Guy Andry; Missak Haigentz; Robert P Takes; Carl E Silver; Dana M Hartl; Primož Strojan; Alessandra Rinaldo; Remco de Bree; Andreas Dietz; Vincent Grégoire; Vinidh Paleri; Johannes A Langendijk; Vincent Vander Poorten; Michael L Hinni; Juan P Rodrigo; Carlos Suárez; William M Mendenhall; Jochen A Werner; Eric M Genden; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-13       Impact factor: 2.503

Review 5.  Current concepts of surveillance and its significance in head and neck cancer.

Authors:  Kapila Manikantan; Raghav C Dwivedi; Suhail I Sayed; K A Pathak; Rehan Kazi
Journal:  Ann R Coll Surg Engl       Date:  2011-11       Impact factor: 1.891

6.  Head and neck squamous cell cancers: need for an organised time-bound surveillance plan.

Authors:  Rehan Kazi; Kapila Manikanthan; K A Pathak; Raghav C Dwivedi
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-11       Impact factor: 2.503

7.  [Argon plasma coagulation (APC) for palliative treatment of tracheostomal recurrences].

Authors:  U Hauser; T K Hoffmann; H Balló; M Sarbia; H Bier
Journal:  HNO       Date:  2003-04-08       Impact factor: 1.284

8.  Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck.

Authors:  Panagiotis Balermpas; Markus Hambek; Oliver Seitz; Claus Rödel; Christian Weiss
Journal:  Strahlenther Onkol       Date:  2009-12       Impact factor: 3.621

9.  CT-guided iodine-125 seed permanent implantation for recurrent head and neck cancers.

Authors:  Yu L Jiang; Na Meng; Jun J Wang; Ping Jiang; Hui Sh Yuan; Chen Liu; Ang Qu; Rui J Yang
Journal:  Radiat Oncol       Date:  2010-07-30       Impact factor: 3.481

10.  An investigation of 125I seed permanent implantation for recurrent carcinoma in the head and neck after surgery and external beam radiotherapy.

Authors:  Lihong Zhu; Yuliang Jiang; Junjie Wang; Weiqiang Ran; Huishu Yuan; Chen Liu; Ang Qu; Ruijie Yang
Journal:  World J Surg Oncol       Date:  2013-03-08       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.